What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin?
暂无分享,去创建一个
[1] M. Borner,et al. More is not always better: a case for low-dose leucovorin. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] J. Habrand,et al. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] E. Aulbert,et al. Fluorouracil als Monotherapie oder in Kombination mit Folinsäure in der Behandlung des metastasierten kolorektalen Karzinoms , 1992 .
[4] D. Harrington,et al. Meta-analyses need new publication standards. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] C. Anderson. Congress looks for methods to assess clinical research , 1992, Nature.
[6] C. Boni,et al. Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC). , 1992, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] C. Erlichman,et al. Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. , 1992, European journal of cancer.
[8] P. Piedbois. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] R. Simon,et al. Bayesian subset analysis in a colorectal cancer clinical trial. , 1992, Statistics in medicine.
[10] K. Matthay,et al. Role of radiotherapy in neuroblastoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Doroshow,et al. Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J. Laurie,et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Hannigan,et al. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] N. Petrelli,et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] R. Prentice. Surrogate endpoints in clinical trials: definition and operational criteria. , 1989, Statistics in medicine.
[16] C. Erlichman,et al. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] N. Petrelli,et al. A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] J. Fourtillan,et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] N. Petrelli,et al. Phase I-II trial of high-dose calcium leucovorin and 5-fluorouracil in advanced colorectal cancer. , 1984, Cancer research.
[20] M. Hakala,et al. Relationship of dUMP and free FdUMP pools to inhibition of thymidylate synthase by 5-fluorouracil. , 1984, Molecular pharmacology.
[21] J. Misset,et al. Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. , 1982, Cancer treatment reports.
[22] S. Waxman,et al. The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherol , 1982 .
[23] J. Laskin,et al. Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil. , 1981, Cancer research.
[24] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .